Back to search

Article

HPGDS as a biomarker for prognosis and immunotherapy in pancreatic cancer

2025-05-19

Abstract excerpt

<title>Abstract</title> <p>Pancreatic ductal adenocarcinoma (PDAC), a highly aggressive malignancy with a poor prognosis, is partly attributed to its immunosuppressive microenvironment. Hematopoietic prostaglandin D synthase (HPGDS), a key enzyme in prostaglandin D2 biosynthesis, plays a significant role in lipid metabolism and inflammatory signalling. Here, we comprehensively investigated the expression profile,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
39cd23d5-8790-5afa-b2db-8b0f37cae4ad
DOI
10.21203/rs.3.rs-6637568/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HPGDS as a biomarker for prognosis and immunotherapy in pancreatic cancerDOI 10.21203/rs.3.rs-6637568/v1
Select a neighboring publication to make it the new centre.